Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
April 06, 2023
From CNBC.com News
From CNBC.com News
J&J backs out of RSV vaccine race with rivals Pfizer and GSK
March 29, 2023
From CNBC.com News
BioNTech shares slip on gloomy Covid vaccine sales outlook
March 27, 2023
From CNBC.com News
From CNBC.com News
Pfizer's Covid drug Paxlovid may reduce the risk of developing long Covid, study says
March 24, 2023
From CNBC.com News
FDA advisors recommend full approval of Pfizer Covid treatment Paxlovid for adults 50 and over and other high-risk people
March 16, 2023
From CNBC.com News
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
March 15, 2023
From CNBC.com News
From CNBC.com News
FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults
March 14, 2023
From CNBC.com News
CNBC Daily Open: Banks got hammered by SVB's collapse. But the Fed might still raise rates
March 14, 2023
From CNBC.com News
From CNBC.com News
Pfizer CEO says it will be able to deliver Seagen's cancer therapy at a scale not seen before with $43 billion deal
March 13, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
FDA says Guillain-Barre syndrome is possible risk of Pfizer's RSV vaccine for older adults
February 24, 2023
From CNBC.com News
Cramer's lightning round: Pfizer is a buy in a market slowdown
February 21, 2023
From CNBC.com News
From CNBC.com News
Eli Lilly recruits Black patients for Alzheimer trial as drugmakers seek more diversity in clinical studies
February 16, 2023
From CNBC.com News
U.S. plans to stop buying Covid shots for the public this fall. Here's what that means
February 04, 2023
From CNBC.com News
The end of the Covid health emergency won't slow FDA clearance of shots and treatments
January 31, 2023
From CNBC.com News
Stocks making the biggest moves premarket: McDonald's, UPS, General Motors and more
January 31, 2023
From CNBC.com News
Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022
January 31, 2023
From CNBC.com News
5 things to know before the stock market opens Monday, January 30
January 30, 2023
From CNBC.com News
From CNBC.com News
Stocks making the biggest moves midday: Chevron, Tesla, Seagate Technology, United Rentals and more
January 26, 2023
From CNBC.com News
FDA has not observed stroke risk among seniors who received Pfizer booster after extensive review
January 26, 2023
From CNBC.com News
Stocks making the biggest moves premarket: Southwest, Tesla, Las Vegas Sands and more
January 26, 2023
From CNBC.com News
Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says
January 25, 2023
From CNBC.com News
Moderna, Pfizer's new race: The RSV vaccine FDA approval process
January 18, 2023
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.